Clinical significance of teratocarcinoma-derived growth factor-1 in serum of human colon cancer patients

FAN Yu,WANG Chong-qiang,ZHANG You-li,WU Ying,CAO Liang
DOI: https://doi.org/10.13312/j.issn.1671-7783.2007.06.019
2007-01-01
Abstract:Objective: To explore the clinical significance of serum teratocarcinoma-derived growth factor 1(TDGF1) in patients with colorectal cancer.Methods: Serum TDGF1 levels of 39 patients with colon cancer were measured by sandwich enzym-linked immunosorbent assay(ELISA).and 36 normal healthy volunteers served as control. Results: The serum TDGF1 level of patients with colorectal cancer was significantly higher than that of the control group(P<0.0001).The serum TDGF1 level in colorectal cancer patients with lymph node metastasis,liver metastasis and Duke′s stage were significantly higher than that in colorectal carcinoma patients without lymph node metastasis,liver metastasis,and Duke′s stage,respectively. Conclusion: Serum TDGF1 may be used as a new tumor marker of colorectal cancer for diagnosis and evaluating the progress.
What problem does this paper attempt to address?